Ischemic preconditioning attenuates portal venous plasma concentrations of purines following warm liver ischemia in man

European Surgical Research

Volumn 37, Issue 3, 2005, Pages 144-152

  Chouker A ^a   Martignoni, A ^a   Schauer, R J ^b   Rau, H G ^b   Volk, A ^b   Heizmann, O ^b   Dugas, M ^a   Messmer, K ^b   Peter, K ^a   Thiel, M ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adenine nucleotides; Hepatectomy; Preconditioning; Reperfusion

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; HYPOXANTHINE; INOSINE; PURINE; XANTHINE;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD LEVEL; CLAMP; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIA; LIVER ISCHEMIA; PARTIAL HEPATECTOMY; PORTAL VEIN BLOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION;

ADENOSINE; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONSTRICTION; HEMOSTASIS, SURGICAL; HEPATECTOMY; HUMANS; HYPOXANTHINE; ISCHEMIA; ISCHEMIC PRECONDITIONING; LACTIC ACID; LIVER; OSMOLAR CONCENTRATION; PORTAL VEIN; PURINES; XANTHINE;

EID: 23844500819     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085961     Document Type: Article

References (22)

1. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello Catafau J: Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 1997;25: 934-937.
2. 2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000;32:297-302.
3. 2 receptors. Hepatology 1999;29:126-132.
4. Moser GH, Schrader J, Deussen A: Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989;256:C799-C806.
5. Pocock SJ: The size of a clinical trial; in Stuart SJ (ed): Clinical Trials. A Practical Approach. Chichester, Wiley, 1996, pp 123-141.
6. Rau HG, Schardey HM, Buttler E, Reuter C, Cohnert TU, Schildberg FW: A comparison of different techniques for liver resection: Blunt dissection, ultrasonic aspirator and jet-cutter. Eur J Surg Oncol 1995;21:183-187.
7. Hagemeier E, Kemper K, Boos KS, Schlimme E: On-line high-performance liquid affinity chromatography-high-performance liquid chromatography analysis of monomeric ribonucleoside compounds in biological fluids. J Chromatogr 1983;282:663-669.
8. Ontyd J, Schrader J: Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr 1984;307:404-409.
9. De Jong JW, de Jonge R, Keijzer E, Bradamante S: The role of adenosine in preconditioning. Pharmacol Ther 2000;87:141-149.
10. Howell JG, Zibari GB, Brown MF, Burney DL, Sawaya DE, Olinde JG, Granger DN, McDonald JC: Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 2000;69:300-303.
11. 2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999;126:945-954.
12. Hawaleshka A, Jacobsohn E: Ischaemic preconditioning: Mechanisms and potential clinical applications. Can J Anaesth 1998;45:670-682.
13. Alkhulaifi AM: Preconditioning the human heart. Ann R Coll Surg Engl 1997;79:49-54.
14. Clavien PA, Yadav S, Sindram D, Bentley RC: Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232:155-162.
15. Choukèr A, Schachtner T, Schauer R, Dugas M, Löhe F, Martignoni A, Pollwein B, Niklas M, Rau HG, Jauch KW, Peter K, Thiel M: Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: A randomised trial. Br J Anaesth 2004;93:204-211.
16. Choukèr A, Martignoni A, Schauer RJ, Dugas M, Rau HG, Jauch KW, Peter K, Thiel M: Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: The role of neutrophils. Arch Surg 2005;140:129-136.
17. Peralta C, Closa D, Xaus C, Gelpi E, Rosello Catafau J, Hotter G: Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998;28:768-773.
18. Peralta C, Bartons R, Riera L, Manzano A, Xaus C, Gelpi E, Rosello Catafau J: Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol 2000;279:G163-G171.
19. Yoshizumi T, Yanaga K, Soejima Y, Maeda T, Uchiyama H, Sugimachi K: Amelioration of liver injury by ischaemic preconditioning. Br J Surg 1998;85:1636-1640.
20. Murry CE, Richard VJ, Reimer KA, Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.
21. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843-850.
22. 2A receptors. Annu Rev Immunol 2004;22:657-682.